These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 31167919)

  • 1.
    Meng T; Jia Q; Wong SM; Chua KB
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
    Meng T; Wong SM; Chua KB
    J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
    Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
    J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
    Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
    Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Caine EA; Osorio JE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
    Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.
    Ku Z; Ye X; Shi J; Wang X; Liu Q; Huang Z
    J Virol; 2015 Dec; 89(23):12084-95. PubMed ID: 26401034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
    Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
    Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71.
    Kang N; Gao H; He L; Liu Y; Fan H; Xu Q; Yang S
    J Ethnopharmacol; 2021 Feb; 266():113401. PubMed ID: 32980486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice.
    Ke X; Zhang Y; Liu Y; Miao Y; Zheng C; Luo D; Sun J; Hu Q; Xu Y; Wang H; Zheng Z
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32823486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor.
    Wu KX; Chu JJ
    Antiviral Res; 2017 Jul; 143():122-133. PubMed ID: 28427827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection.
    Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J
    Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71.
    Yamayoshi S; Iizuka S; Yamashita T; Minagawa H; Mizuta K; Okamoto M; Nishimura H; Sanjoh K; Katsushima N; Itagaki T; Nagai Y; Fujii K; Koike S
    J Virol; 2012 May; 86(10):5686-96. PubMed ID: 22438546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Coxsackievirus A6- and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing, China, from 2013 to 2015.
    Li J; Sun Y; Du Y; Yan Y; Huo D; Liu Y; Peng X; Yang Y; Liu F; Lin C; Liang Z; Jia L; Chen L; Wang Q; He Y
    Front Microbiol; 2016; 7():391. PubMed ID: 27065963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication and cytokine profiles of different subgenotypes of enterovirus 71 isolated from Thai patients in peripheral blood mononuclear cells.
    Wongsa A; Noulsri E; Phawong C; Puthavathana P; Tassaneetrithep B
    Microb Pathog; 2019 Jul; 132():215-221. PubMed ID: 31075431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding.
    Yu J; Dai Y; Fu Y; Wang K; Yang Y; Li M; Xu W; Wei L
    Antiviral Res; 2021 Mar; 187():105021. PubMed ID: 33508330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.
    Caine EA; Moncla LH; Ronderos MD; Friedrich TC; Osorio JE
    J Virol; 2016 Oct; 90(19):8592-604. PubMed ID: 27440896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
    Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.